Jane Street’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$314K Buy
+17,791
New +$197K ﹤0.01% 9077
2023
Q3
– Sell
-1,041
Closed -$22.4K – 8656
2023
Q2
$22.4K Buy
1,041
+1
+0.1% +$27 ﹤0.01% 8347
2023
Q1
$29.2K Sell
1,040
-4,749
-82% -$142K ﹤0.01% 8580
2022
Q4
$130K Buy
5,789
+1,161
+25% +$26.5K ﹤0.01% 7958
2022
Q3
$111K Buy
4,628
+2,505
+118% +$80.8K ﹤0.01% 8590
2022
Q2
$62K Buy
2,123
+1,084
+104% +$48.4K ﹤0.01% 8855
2022
Q1
$97K Buy
+1,039
New +$90.3K ﹤0.01% 9468
2021
Q3
– Sell
-2,087
Closed -$615K – 9934
2021
Q2
$615K Buy
+2,087
New +$617K ﹤0.01% 6853
2020
Q3
– Sell
-1,373
Closed -$371K – 7158
2020
Q2
$371K Buy
+1,373
New +$376K ﹤0.01% 5513

Other funds holding BNR

Jane Street's BNR Position: Q3 2026 in Review

Jane Street opened a new position in Burning Rock Biotech (BNR) in Q3 2026: 17,791 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #9077 among its holdings. This is a return to the name: Jane Street previously reported a position in BNR as recently as Q2 2023.

Jane Street first reported a position in BNR in Q2 2020 and has held it in 9 quarters since. The position peaked at $615K in Q2 2021. 14 funds tracked by Wall St. Rank hold BNR as of Q3 2026.

  • Jane Street held 17,791 shares of Burning Rock Biotech worth $314K as of Q3 2026.
  • Burning Rock Biotech was a new Jane Street position in Q3 2026.
  • Burning Rock Biotech made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9077 holding.
  • Jane Street first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 9 quarters since.
  • Jane Street's Burning Rock Biotech position peaked at $615K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.